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ABSTRACT: Exosomes contain cell- and cell-state-speciﬁc cargos of proteins, lipids, and nucleic acids and play signiﬁcant roles
in cell signaling and cell−cell communication. Current research into exosome-based biomarkers has relied largely on analyzing
candidate biomarkers, i.e., speciﬁc proteins or nucleic acids. However, this approach may miss important biomarkers that are yet
to be identiﬁed. Alternative approaches are to analyze the entire exosome system, either by “omics” methods or by techniques
that provide “ﬁngerprints” of the system without identifying each individual biomolecule component. Here, we describe a
platform of the latter type, which is based on surface-enhanced Raman spectroscopy (SERS) in combination with multivariate
analysis, and demonstrate the utility of this platform for analyzing exosomes derived from diﬀerent biological sources. First, we
examined whether this analysis could use exosomes isolated from fetal bovine serum using a simple, commercially available
isolation kit or necessitates the higher purity achieved by the “gold standard” ultracentrifugation/ﬁltration procedure. Our data
demonstrate that the latter method is required for this type of analysis. Having established this requirement, we rigorously
analyzed the Raman spectral signature of individual exosomes using a unique, hybrid SERS substrate made of a graphene-
covered Au surface containing a quasi-periodic array of pyramids. To examine the source of the Raman signal, we used Raman
mapping of low and high spatial resolution combined with morphological identiﬁcation of exosomes by scanning electron
microscopy. Both approaches suggested that the spectra were collected from single exosomes. Finally, we demonstrate for the
ﬁrst time that our platform can distinguish among exosomes from diﬀerent biological sources based on their Raman signature, a
promising approach for developing exosome-based ﬁngerprinting. Our study serves as a solid technological foundation for
future exploration of the roles of exosomes in various biological processes and their use as biomarkers for disease diagnosis and
treatment monitoring.
KEYWORDS: exosome, surface-enhanced Raman spectroscopy, graphene, principal component analysis, biomarker
Extracellular vesicles (EVs) are complex structurescomprising a lipid bilayer that contains transmembrane
proteins and encloses soluble hydrophilic components derived
from the cytosol or other organelles of the donor cell.1
Exosomes are the most abundant and best-characterized type
of EVs, ranging from 30 to 200 nm in diameter. They are
produced via the endosomal pathway and are released into the
extracellular space from multivesicular bodies.2 Exosomes play
an important role in intercellular communication by trans-
ferring biochemical messages among cells.3 They contain
abundant proteins, lipids, and nucleic acids, including mRNA
and miRNA, and mediate a wide variety of biological
functions.4 Exosomes have attracted attention for their role
in spreading of diseases throughout the aﬀected tissue5−9 and
as a valuable source of biomarkers for diagnosing various
diseases, including cancer and neurodegenerative diseases.
However, exosome research is still a young ﬁeld. The scope of
biological functions mediated by exosomes and the mecha-
nisms by which they are released from the cells of origin and
taken up by recipient cells are yet to be fully elucidated.10−13
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Raman spectroscopy is a widely used, label-free, non-
destructive method. It has been used for extracting
spectroscopic information originating from chemical bonding
in molecules, which can in turn be used as ﬁngerprints by
which molecules are identiﬁed.14 The label-free nature of
Raman spectroscopy has made it a powerful option for studies
of biological samples.15 The most noticeable drawback of
Raman spectroscopy, however, is the low yield of Raman
scattering events leading to low detection sensitivity.16
Thankfully, this shortcoming can be overcome by placing the
analytes within a few tens of nanometers of nanostructured
metallic surfaces,17−20 a method known as surface-enhanced
Raman spectroscopy (SERS) which has been employed
extensively and has been demonstrated to have single-molecule
sensitivity.33 One of the unique characteristics of SERS is its
very high spatial resolution. When applied to exosomes, the
typical lateral spatial separation of SERS hotspotstens of
nanometers apartmakes it inherently a single-exosome
analysis even though the typical laser spot size is ∼1 μm.
The quadratic dependence of SERS signal intensity on the
local electromagnetic ﬁeld intensity allows the signal from a
single plasmonic hotspot to dominate the spectrum
collected.21
We used a unique plasmonic hybrid platform consisting of a
single-layer graphene overlaid on a carefully engineered
periodic Au-pyramid nanostructure. The metallic nanostruc-
tured surface provides an intense surface plasmonic ﬁeld upon
laser illumination and thus enhances the Raman signal by
many orders of magnitude. The graphene layer serves a dual
purpose, providing a biocompatible and chemically stable
surface, and serving as a built-in gauge of local electromagnetic
ﬁeld intensity enabling quantitative Raman analysis.22
Previously, the Xie group demonstrated the biocompatibility
of the graphene layer successfully by culturing epithelial cells
from colon or colon cancer over graphene.23 Reports by several
other groups have also supported the biocompatibility of
graphene.24−27 A critical component of our platform is data
analysis used to discern and categorize spectral signatures.
Programs suitable for such analysis belong generally in the
realm of artiﬁcial intelligence. Here, we used a multivariate
analysis algorithm known as principal component analysis
(PCA).
Our proof-of-concept study presented here contains three
parts: (1) characterization of exosomes prepared by two
distinct methods and determination of the most suitable one
for SERS analysis; (2) establishing the methodology for
measuring the Raman signature from single exosomes; and (3)
using unbiased PCA to demonstrate unequivocally the
separation of exosomes from diﬀerent biological sources.
■ RESULTS AND DISCUSSION
Comparison of Exosome Isolation Methods. Two main
approaches are used to isolate exosomes. Because they are
enclosed by hydrophobic membranes, exosomes (and other
EVs) can be precipitated out of solution using simple salting-
out reagents, often in the presence of water-soluble polymers,
generating relatively heterogeneous mixtures of exosomes,
ectosomes, and some protein aggregates and cell debris.
Alternatively, a series of diﬀerential centrifugation, ultra-
ﬁltration, and ultracentrifugation steps10 (heretofore referred
to as ultracentrifugation/ﬁltration (UC/F) method) yields
relatively pure exosomes and is considered the “gold standard”
Figure 1. Comparison of exosomes isolated by the ultracentrifugation/ﬁltration method versus the ExoQuick kit. (A) DLS spectra showing the
particle size distribution of exosomes isolated by UC/F, (black) or by ExoQuick (EQ, red). (B) TRPS analysis of exosomes isolated by the UC/F
method. (C) TRPS analysis of exosomes isolated by the ExoQuick kit. (D, E) Representative TEM image of exosomes isolated by UC/F (D) or
ExoQuick (E) at 80,000× magniﬁcation. The scale bars in both panels represent 200 nm. The insets show zoomed-in images of a single exosome in
each preparation, in which the lipid bilayer is clearly visible. (F) Western blot detecting the exosomal markers Alix, CD9, and CD81. TS: total
serum.
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in the ﬁeld. Each method has distinct advantages and
disadvantages. The salting-out procedure, often done using
commercial kits, such as ExoQuick (Systems Biosciences),28 is
fast and yields nearly 3 orders of magnitude more material,29
but the resultant EV population is more heterogeneous. In
contrast, the UC/F procedure excludes much of the
nonexosome components, but it is time-consuming and
labor-intensive, achieves low yields, thus requiring larger
volume of the initial sample, and can only be used if
subsequent analyses are done using high-sensitivity methods.
We reasoned that because SERS is a high-sensitivity method,
the latter procedure could be used, yet decided to compare the
two methods because if using the ExoQuick kit could yield
high-quality data, it would require lower sample volumes and
allow processing more samples faster.
To compare the two methods, we used fetal bovine serum
(FBS). Following isolation of exosomes by each method, we
compared the size distributions of the vesicles using dynamic
light scattering (DLS). DLS showed that the UC/F procedure
yielded a particle distribution with ∼20 nm maximum
hydrodynamic diameter (Figure 1A). Larger particles, up to
∼1000 nm, also were observed, suggesting that the preparation
also contained some ectosomes and potentially cell debris. It is
important to remember that the contribution of large particles
is highly overrepresented by DLS because the intensity of the
DLS signal is proportional to the square of the particle mass.
The ExoQuick kit yielded a broader size distribution of
particles compared to those by UC/F (Figure 1A), comprising
three peaks at hydrodynamic diameter ∼30, 300, and 6000 nm.
These data demonstrated that the ExoQuick preparation
contained larger particles, yet suggested that the vast majority
of the particles comprising the mixture in both cases were in
the 30−200-nm-diameter range, consistent with exosomes.
To further assess the particle size distributions of the two
preparations using a method that does not overemphasize
larger particles, we used tunable resistive pulse sensing
(TRPS). For the UC/F preparation, TRPS showed a single
peak with a mean diameter of 135 ± 33 nm and a d90 value of
165 nm (i.e., 90% of the vesicles had a diameter below 165 nm,
Figure 1B). The ExoQuick preparation yielded a similar
distribution, though as might be expected, the mean diameter
was somewhat larger than that of particles obtained by UC/F,
143 ± 47 nm, and the d90 value was 189 (Figure 1C).
We also characterized the morphology of the particles in
each preparation by transmission electron microscopy (TEM).
TEM showed that exosomes of similar sizes existed in both
preparations (Figure 1D, E), yet the ExoQuick-isolated
population contained more structures that looked like cell
debris. High-resolution images of single exosomes clearly
showed the lipid bilayer enclosing them (Figure 1D, E insets).
Finally, to conﬁrm that both preparations contained bona f ide
exosomes, we used Western blotting to detect exosomal
protein markers Alix, CD9, and CD81 (http://www.exocarta.
org) (Figure 1F). Western blotting conﬁrmed that these
markers were enriched in both populations compared to the
original FBS.
Measurement of the protein content in each preparation
using the bicinchoninic acid (BCA) assay showed that the
amount of protein in the ExoQuick preparation was ∼850
times higher than that in the UC/F preparation. This
substantially higher yield represents both the somewhat more
heterogeneous nature of the EV population isolated by the
ExoQuick kit and the loss of a large portion of the exosomes
during the UC/F process.
SERS Hybrid System for Measuring the Raman
Spectra of Exosomes. To collect the Raman signature of
exosomes, we used a plasmonic substrate consisting of a
graphene layer on top of an Au surface with periodic pyramidal
structures, heretofore referred to as a “hybrid substrate”.30−32
A schematic of the hybrid substrate is shown in Figure 2A and
Figure 2. SERS hybrid platform. (A) Schematic diagram of the hybrid platform used in this study. (B) Top-view SEM image of the hybrid platform.
(C) Electromagnetic ﬁeld distribution simulated by FDTD at an input wavelength of 785 nm. The color bar represents the intensity of the electric
ﬁeld. (D) Representative Raman spectrum of the hybrid platform showing the graphene peaks.
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a top view by scanning electron microscopy (SEM) is provided
in Figure 2B. The base dimensions of the pyramids are ∼200 ×
200 nm2 and the center-to-center distance between adjacent
pyramids is ∼400 nm. The angle of the sidewalls of the
pyramids is 57.5°, deﬁned by the {111} facets of (001)
oriented Si crystal/wafer used to produce the pyramids.
Previously, this hybrid substrate was demonstrated to have a
Raman enhancement factor of up to 1012.33
The quasi-periodic Au nanopyramid structure was fabricated
using a patterning method via a layer of self-assembled
polystyrene balls, providing a reproducible and uniform SERS
response. Such a fabrication process can be easily scaled up for
mass production using silicon-integrated-circuit technology.34
The graphene layer placed on top of the metal surface provides
a biocompatible surface, independent of the type of metal used,
for supporting plasmon resonance. The local electromagnetic
ﬁeld distribution on the hybrid substrate can be simulated
using a ﬁnite-diﬀerence time-domain method (FDTD).35 A
typical result of such a simulation shows that the hotspots,
where the electromagnetic ﬁeld is highly enhanced, are on each
side of the nanopyramids (Figure 2C). The Raman spectrum
of the hybrid substrate, reﬂecting the graphene peaks is shown
in Figure 2D.
The graphene layer is chemically inert and impermeable
even to He atoms,36 protecting the metallic nanostructures
from possible corrosion, including oxidation, and preventing
biological substrates, such as cells, from undesired negative
eﬀects of the metal surface. The Raman signal of the graphene
layer also serves as a built-in gauge of the local electromagnetic
ﬁeld intensity. By using this built-in gauge, the intensity of
Raman peaks in the biological analytes can be correlated
uniquely to the amount of the analytes present within a
hotspot, as opposed to being a convolution between the local
EM ﬁeld intensity and the amount of the protein. Therefore,
the Raman signal intensity from diﬀerent sets of hybrid
substrates or diﬀerent spots measured on the same substrate
can be compared quantitatively by normalizing the signal to
the graphene Raman peaks.
After establishing the diﬀerences and similarities between
the two exosome-preparation methods, we used the hybrid
substrate to collect SERS spectra and test if one or both
preparation methods yielded useful Raman ﬁngerprint
information. The sample volume was adjusted so that the
same total protein concentration was used in each case. For
each sample, 100 SERS spectra were collected over distinct
spots so that no two spectra were collected from the same
portion of the sample. The analysis showed a striking
diﬀerence between the two populations. Although both
samples contained the same amount of total protein, the
Raman spectra of the ExoQuick preparation (Figure 3A) had a
substantially higher absolute intensity than those in the UC/F
preparation (Figure 3B), likely due to the contribution of cell
debris, protein aggregates, and/or other nonexosome compo-
nents. In the UC/F preparation, the spectra showed high
homogeneity allowing detection of multiple peaks, including
minor ones of intensity <50 au. In contrast, overlapping spectra
of the ExoQuick preparation yielded a highly heterogeneous
picture, in which locating useful representative data was
impractical. This analysis made it clear that the ExoQuick
preparation could not be used for obtaining SERS ﬁngerprints
in this system, whereas the UC/F method oﬀered abundant
useful information. To extract the information generated from
the SERS analysis of UC/F-isolated exosomes, we averaged the
100 spectra collected (Figure 3B) and could assign 15 distinct
peaks in this averaged spectrum (Figure 3C) using known
assignments of Raman spectra in biological samples37 (Table
1).
Though we have chosen to use the ExoQuick kit, other
commercial kits exist for isolation of exosomes using similar
methods and our data suggest that these kits generally are
Figure 3. Raman spectra of exosomes collected using the two preparation methods. (A) Raman spectra of exosomes isolated from FBS using the
ExoQuick kit. (B) Raman spectra of exosomes isolated from FBS using UC/F. (C) Averaged spectrum of the 100 overlaid spectra in panel B. The
wavelengths of assigned peaks are indicated above the peaks themselves.
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incompatible with SERS analysis due to inclusion of
nonexosome components that decreases the signal-to-noise
ratio. It is possible, however, that improved techniques, such as
the recent ExoQuick-Ultra kit, which adds another puriﬁcation
step, will yield exosome populations amenable to SERS, and
testing such improved methods will be examined in future
studies. (In this context, signal-to-noise refers to the
reproducible observation of certain Raman peaks from putative
single exosomes in the UC/F preparation (Figure 3B) as
opposed to the multiple non-overlapping spectra in the
ExoQuick preparation, which indicated high sample hetero-
geneity.)
Considering the results discussed above (Figure 3A, B), we
focused the rest of the study on exosomes prepared using the
UC/F method. Our next goal was to validate that the Raman
spectra measured using the hybrid system were from single
exosomes. Because of the small size of the exosomes, 30−200
nm, the limited spatial resolution of an optical microscope
attached to the Raman spectrometer did not allow direct
visualization of individual exosomes for the purpose of
determining the source of the Raman spectra. Therefore, we
used SEM, which has suﬃcient spatial resolution for observing
exosomes, but requires a separate measurement. To correlate
between SEM visualization and Raman signature measure-
ments, we conducted serial-dilution experiments, in which we
used either the unaltered exosome preparation or samples
diluted 3- or 10-times. We collected Raman spectra across a 10
× 10-pixel area at each concentration (Figure 4A−C) and
visualized the same hybrid substrates by SEM (Figure 4F). The
pixel size of the Raman map was set at 2 μm to avoid overlap
of adjacent laser spots. The Raman mapping results of the
three samples showed a density change consistent with the
change of the sample concentration.
As a test for the presence of exosomes in each spectrum, we
chose three spectral peaks with high signal-to-noise ratios at
1012 (Figure 4D, red pixels), 1509 (yellow pixels), and 1613
(blue pixels) cm−1 representing the vibrational mode of
phenylalanine, the ring-breathing mode in DNA bases, and the
Raman mode of tyrosine, respectively. It should be noted that
to observe the 1613 cm−−1 peak, we subtracted the graphene
G-peak, which normally masks the 1613 cm−1 peak. The
position of the graphene G-peak is stably at 1583 cm−1 and its
intensity can vary depending on the layer number. Here, we
used a single-layer graphene with 97% uniformity, measured a
background spectrum of the graphene signal in the absence of
the biological sample, scaled the intensity so that the amplitude
of the G-peak in this background spectrum matched that of the
exosome-measurement spectrum, and subtracted the G-peak
using the built-in function of Reinshaw WiRe 4.2 software.
Such background subtraction is a routine process commonly
applied by Raman spectroscopists. As this was a yes/no type of
analysis, normalizing to the graphene signal was not necessary
in this case.
We postulated that each individual peak in these spectra
might represent sources other than exosomessuch as protein
aggregates or cell debrisbut that appearance of all three
Table 1. Assignment of the Raman Peaks Shown in the
Spectrum in Figure 3
Raman shift
(cm−1) Peak assignment References
716 C−N (membrane phospholipids head) 47, 48
CN−(CH3)3 (lipids)
753 Symmetric breathing of tryptophan 49−51
970 Lipids 52
Phosphate monoester groups of phosphorylated
proteins and nucleic acids
1012 Phenylalanine 53
1044 Proline 54, 55
ν3PO4
3−(symmetric stretching vibration)
1111 Phenylalanine (proteins) 56
1140 Fatty acids 57
1183 Cytosine, guanine, adenine 30
1287 Cytosine 39
1400 CO symmetric stretch 58, 59
CH2 deformation NH in-plane deformation
1438 CH2 and CH3 deformation vibrations,
cholesterol, fatty acid band
60
1510 A (ring-breathing modes in the DNA bases) 29
1566 Tryptophan 61
1592 G (DNA/RNA), CH deformation (proteins, and
carbohydrates)
62
1614 CC stretching mode of tyrosine 30, 38
Figure 4. SERS and SEM mapping of exosomes adsorbed on the
hybrid substrate. (A−C) Raman mapping of the same undiluted (A),
3-times diluted (B), or 10-times diluted (C) exosome preparation.
(D) Pixel assignment for the Raman signature of exosomes. The red,
yellow, and blue pixels represent the presence of 1012, 1509, and
1613 cm−1 peaks in the Raman spectrum, respectively. The black
pixels are those in which all three peaks were detected. Only black
pixels were considered as containing exosomes. (E) Comparison of
the exosome density obtained through Raman mapping and SEM at
three diﬀerent exosome concentrations. (F) A representative 9 × 9-
μm SEM micrograph of exosomes attached to the graphene-covered
surface at 35,000× magniﬁcation. The yellow circles mark the
presence of exosomes within this region.
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peaks in the same spectrum likely represented bona f ide
exosomes. Figure 4D demonstrates that the majority of the
pixels yielding a Raman spectrum other than that of only
graphene contained all three peaks (represented as black
pixels), suggesting that the source of the spectrum in each of
these pixels was an exosome. As expected, the Raman mapping
demonstrated that the density of the black pixels decreased
proportionally with increasing dilution.
After measuring the Raman signature, we used SEM to
determine visually the location of the exosomes on the hybrid
substrate at the same dilutions, counted the exosome number
within randomly selected, 9 × 9 μm2 areas (Figure 4F), and
compared the exosome density with the Raman mapping
results. The exosome density at each concentration was
determined by averaging measurements at ten diﬀerent areas.
Comparison of the exosome density obtained separately using
Raman mapping and SEM showed a strong correlation
between the two methods (Figure 4E). The two measurements
showed similar exosome density at each dilution and the
diﬀerence between them was statistically insigniﬁcant (p =
0.385, two-way ANOVA). In contrast, the diﬀerence among
the three dilutions measured by each method was statistically
signiﬁcant (p = 0.017).
Figure 5. Raman-based topological mapping of an intact individual exosome. (A) Raman spectrum used for generating the topological map. The
graphene D and G peaks and the DNA-base ring-breathing peak at 1509 cm−1 used for generating the map are indicated. (B) Topological map
based on the 1509 cm−1 peak using a step size of 0.1 μm. The peak-intensity changes along the x- and y-axes are shown on the right and top,
respectively.
Figure 6. SERS analysis and PCA of exosomes from diﬀerent sources. (A−C) Raman spectra of exosomes from human serum (A) conditioned
medium of the lung-cancer cell line HCC827 (B), and conditioned medium of the lung-cancer cell line H1975 (C). (D) PCA of exosomes from the
diﬀerent sources shown in panels A−C and the spectrum shown in Figure 3C demonstrating that they are distinguishable.
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Estimation of Exosome Morphology Using High-
Resolution Raman Mapping. In the Raman mapping shown
in Figure 4, we observed variation in the intensity of the
Raman signal from pixel to pixel, primarily due to the existence
of exosomes in some pixels but not others. In addition, the
magnitude of the signal depends on the Gaussian-shaped
exciting laser beam and the proximity of the sample to the
hotspots on the sides of the Au pyramids where the SERS
enhancement is maximal (Figure 1C). Although the data
discussed above supported the interpretation that the Raman
spectra were collected from bona f ide exosomes, they could not
rule out the possibility that the spectra reﬂected a small cell
fragment that happens to contain both proteins and DNA. To
test further if the data were obtained from exosomes, we
reasoned that unlike the spherical shape of exosomes, the
likelihood that cell fragments would be spherical was low.
Therefore, we mapped the topology of the structures giving
rise to the Raman spectra using the intensity of the Raman
spectrum itself by performing high-spatial-resolution Raman
mapping with 0.1-μm ﬁne-step size (Figure 5). Examination of
the Raman spectra emanating from a single source on the
surface of the hybrid substrate showed multiple peaks, among
which the graphene G-peak was easily identiﬁed (Figure 5A).
In this set of experiments, we did not subtract this peak, but
rather used it to normalize the Raman signal intensity at each
laser-beam step to eliminate the inﬂuence of unavoidable
hotspot intensity ﬂuctuations. Therefore, the peak at 1613
cm−1 used in the previous experiments (Figure 4) was not
included in this morphological analysis. Because the 1509 cm−1
peak was the more intense of the two remaining peaks (Figure
5A), we used the intensity of this peak to generate a
topological map based on the intensity of the signal at each
step and reconstructed a 3-D map of peak-intensity changes
along the x- and y-axes (Figure 5B). The resulting high-
resolution topological map showed a quasi-spherical structure
supporting the notion that the Raman spectra indeed were
collected from individual exosomes. Because the diameter of
the exosomes, 30−200 nm, is smaller than that of the laser
beam, ∼1 μm, the measurement did not allow precise
measurement of exosome diameter.
SERS Platform Distinguishes Exosomes from Diﬀer-
ent Sources. Spectral features of SERS are highly sensitive to
the chemical composition of biomolecules. After establishing
that the SERS spectra likely represented single exosomes, we
asked whether this sensitivity could translate to speciﬁcity,
distinguishing exosomes from diﬀerent sources. This question
is critical for determining the potential value of the SERS
platform for biomedical applications. To address this question,
we compared the spectra of exosomes from diﬀerent sources:
First, we asked if the FBS used for the initial characterization
up to this point (Figure 3C) could be distinguished from
human serum (Figure 6A); second, we asked whether the
human serum exosome spectra could separate them from those
in the conditioned tissue-culture medium of a human lung
cancer cell line; and ﬁnally, as a highly diﬃcult challenge for
the platform, whether the speciﬁcity could be extended to
distinguishing between two lung cancer cell lines, HCC827
(Figure 6B) and H1975 (Figure 6C). We collected 100 Raman
spectra from each sample and assigned all of the identiﬁed
peakscorresponding expectedly to nucleic acids, proteins,
and lipidsand showing both similarities and diﬀerences. The
complete peak assignments are provided in Supplementary
Tables S1 (human serum), S2 (HCC827), and S3 (H1975).
Each sample showed uniquely identiﬁable spectral character-
istics distinguished primarily by the relative peak intensities.
For example, the relative intensity of nucleic-acid bands was
substantially higher in the human-serum- and FBS-derived
exosomes compared to those from the conditioned media of
the cancer cell lines. The reason for this diﬀerence is not
known at this time and will be explored in future studies. In
contrast, the relative intensity of the lipid bands was clearly
higher in exosomes derived from cancer cells, in agreement
with previous reports suggesting that cancer cells store
excessive amounts of lipids and cholesterol in lipid droplets,
making this feature a hallmark of aggressive cancers.38−40 We
then used PCA to analyze spectral diﬀerences and similarities
in ∼50 Raman spectra from each sample (Figure 6D). The
results showed that the exosomes from all four diﬀerent
sources clustered into distinguishable groups with <5% overlap
among the groups at a sensitivity of >84%. Interestingly, the
largest degree of overlap was not between the two sera or the
two cell lines, but between FBS and the H1975 cell line
(Figure 6D). These ﬁndings suggest that analysis of exosomes
from the serum of two diﬀerent species, cell culture media
versus serum, and cell culture media from two cancer cell lines
of the same human organ, lung, can be distinguished using our
platform. The data suggest that the methodology and platform
developed here have the potential of serving as a unique
biomarker, without requiring knowledge of disease mechanism,
deﬁning speciﬁc candidate biomarkers, or using biological
labels. It should be further pointed out that the ability to
distinguish subtle diﬀerences among Raman spectra from
diﬀerent sources is highly dependent on the data analysis
algorithm. For our study, a more advanced algorithm such as
deep neural network may allow in the future to achieve better
separation than that achievable using PCA.
Recently, a few groups have applied SERS to characterize
exosomes,41−44 yet to our knowledge, our study is the ﬁrst to
demonstrate acquisition of Raman spectra from single
exosomes and diﬀerentiating the exosomes from other EVs
and fragments of various biological entities.
■ CONCLUSION
We have demonstrated the potential of a new SERS-based
platform for identiﬁcation of exosomes from readily available
biological samples and obtaining unique ﬁngerprint signatures
from these exosomes. We showed the reproducibility of the
spectra when the exosomes are isolated by the UC/F method
(Figure 3B) and the ﬁngerprinting capability of the platform by
comparing the spectra of exosomes from four diﬀerent sources.
Using PCA, the platform clusters the spectra of exosomes into
readily distinguishable groups with <5% overlap among
diﬀerent groups at a sensitivity of >84%, which to our
knowledge is higher than what has been reported to date. As an
inherently single-exosome-based and label-free methodology,
the platform holds tremendous and realistic promise for
identifying speciﬁc biomarkers for early stage diagnosis and a
useful research tool for deepening the understanding of the
role of exosomes in normal physiology and disease.
■ EXPERIMENTAL METHODS
Fabrication of Au Nanopyramid Hybrid SERS Substrate. The
hybrid SERS substrate used here was prepared as described
previously.31 Brieﬂy, we generated a template using a single layer of
self-assembled polystyrene balls. The near-hexagonal pitch periodicity
was then transferred to a SiO2 mask over a Si (001) wafer via plasma
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etching. These two methods produce nanometer-scale, 2-D features of
poorly deﬁned shapes. We employed an additional step of anisotropic
etching of Si to transfer the fuzzy 2-D features into well-deﬁned 3-D-
inverted pyramids with facets consisting of {111} planes on a (001)
oriented Si wafer.45 The angle of the sidewalls of the pyramids relative
to their basal plane is 57.5°, determined using crystallography of the Si
crystal. We further employed geometrical hindrance during thermal
oxidation of Si to ﬁne-tune the sharpness of the apex of the inverted
pyramids.39 200-nm-thick Au ﬁlms then were deposited over the
pitted surface, bonded to a handle substrate using epoxy, and then
lifted oﬀ the surface thereby completing the nanocasting process.
Because of the way the substrate was fabricated, the Au-tipped surface
had the unique features of in-plane anisotropy and wafer-scale
coherence with the precise orientation and shape of individual
pyramids.
Preparation and Transfer of Graphene. 25-μm-thick copper
foil was cut into a 2 × 2-in. square and placed at the center of a quartz
chemical vapor deposition (CVD) tube of 15 cm diameter to serve as
a catalyst during CVD growth. The furnace was heated to ∼1060 °C
under H2 ﬂow at 1 Torr total pressure. After 30 min annealing, growth
commenced under 20 Torr total pressure with a ﬂow of CH4 (∼20
standard cubic centimeter per minute (sccm)) and H2 (∼1000 sccm)
for 15 min. The chamber was cooled down to room temperature over
10 h. A ∼500 nm poly(methyl methacrylate) (PMMA) layer was spin-
coated on the graphene-covered Cu foil to provide mechanical
support to the graphene monolayer during the subsequent Cu-etching
step. The Cu foil was removed in an etching solution of FeCl3:H2O
(1:5 vol %). Then, the ﬂoating PMMA−graphene structure was
transferred onto the surface of deionized water and the sample was
transferred onto a target substrate. In the ﬁnal step, the PMMA-
supporting layer was removed by acetone.
Raman Spectroscopy. Raman spectra were recorded using a
Renishaw inVia Raman spectrometer under ambient conditions (20
°C and 1 atm). WiRe 4.2 software was used to control the entire
system. The laser excitation wavelength was 785 nm, which generates
a low ﬂuorescence background but still has a strong localized
electromagnetic ﬁeld.24 The power of the laser was kept at 5 mW to
avoid sample overheating. The diameter of the laser spot was 1.8 μm.
The Raman measurements were calibrated ﬁrst by the Si Raman
mode at 520 cm−1. Then, 2 μL of the exosome solutions were applied
to the hybrid platform surface and allowed to air-dry before the
measurement. The acquisition time was 1 s. For coarse Raman
mapping, Raman spectra across a 10 × 10-pixel area were collected
with a step length of 2 μm. For ﬁne Raman mapping, Raman spectra
across a 10 × 10-pixel area were collected with a step length of 0.1
μm. The acquisition time was 0.2 s to avoid overheating.
Exosome Isolation. FBS was purchased from Invitrogen, USA.
For human serum, peripheral blood was collected from a healthy
volunteer by venipuncture using a BD Vacutainer push-button blood
collection kit and left to coagulate in silicone-coated serum collection
tubes for 20 min at room temperature. After centrifugation at 1500 ×
g for 15 min, the serum was collected and either processed
immediately or stored at −80 °C. The human lung cancer cell
lines, HCC827 and H1975, were obtained from ATCC and cultured
in 75 cm2 tissue-culture ﬂasks. Cells were cultured in exosome-free
conditioned medium, pre-cleared of exosomes and protein aggregates
before use for cell culture by ultracentrifugation. Supernates were
collected 48−72 h after changing the medium for exosome isolation.46
EVs from FBS were isolated using an ExoQuick kit (System
Biosciences, USA) following the manufacturer’s instructions.
For isolation of exosomes using the UC/F method, after thawing
quickly in a 37 °C water bath, protease and phosphatase inhibitors
were added and the serum/media from either source was diluted ﬁve
times in chilled PBS. Cell culture supernates or diluted sera were
centrifuged at 2000 × g and 4 °C for 20 min and then further
centrifuged at 12,000 × g and 4 °C for 45 min to remove small debris.
The supernates were ﬁltered using 0.22-μm-pore ﬁlters, followed by
ultracentrifugation in a Model L8-M70 ultracentrifuge (Beckman
Coulter, USA) at 110,000 × g and 4 °C for 2 h. The resulting pellets
were resuspended in chilled PBS and ultracentrifuged again at
110,000 × g and 4 °C for 70 min. The ﬁnal pellet of exosomes was
resuspended in 50−100 μL chilled PBS for TRPS measurement, in a
2% glutaraldehyde or 2% paraformaldehyde (PFA) solution in Milli-Q
water for SERS and TEM experiments, respectively, or lysed in RIPA
buﬀer, aliquoted, and stored at −80 °C for Western blot analysis.
Dynamic Light Scattering. The size distribution (hydrodynamic
diameter) of exosomes was determined using a Zetasizer Nano
instrument (Malvern Instruments Ltd., Worcestershire, UK). After
isolation, the exosome pellet was reconstituted in 100 μL of ﬁltered
PBS. 50 μL of puriﬁed exosomes were diluted in 1450 μL of ﬁltered
PBS and gently vortexed for 30 s to avoid aggregation. The whole
volume was quickly transferred into a disposable cuvette and allowed
to equilibrate for 30 s at 25 °C. A 20 mW He−Ne laser operating at
632 nm was used at an angle of 173°. The dispersant refractive index
value used was 1.37. The size of the observed particle populations was
determined by Z-average and polydispersity index (PdI). Three
independent measurements of 14 counts each were performed per
sample and average values are presented.
Tunable Resistive Pulse Sensing (TRPS). TRPS measurements
were performed using a qNano instrument (Izon Science,
Christchurch, New Zealand) equipped with a polyurethane nanopore
axially stretched to 48 mm (NP150, Izon Science, UK). All
measurements were calibrated with appropriately diluted CPC200
polystyrene beads (Izon Science, UK). 40 μL samples diluted in PBS
were used for measurement. Data were processed and analyzed using
the Izon Control Suite software v 3.3.2.2001.
Transmission Electron Microscopy (TEM). For TEM examina-
tion of isolated exosomes, pellets obtained after the last centrifugation
step were resuspended in ﬁxative (2% PFA in Milli-Q water). Formvar
carbon-coated grids (FCF400-CU, Electron Microscopy Sciences)
were glow-discharged on a Pelco easiGlow instrument (Ted Pella Inc.,
USA) for 2 min. Small drops of PFA-ﬁxed exosomes then were placed
on the grids and incubated for 20 min. The grids were washed by
ﬂoating them upside down on drops of deionized water. The
exosomes were further ﬁxed in 1% glutaraldehyde for 5 min and then
stained successively in freshly prepared 2% uranyl acetate and 2%
methylcellulose/0.4% uranyl acetate. Grids were imaged using a FEI
Technai T20 transmission electron microscope equipped with a
thermionic tungsten ﬁlament and operated at an acceleration voltage
of 200 kV. Images were taken using a cooled slow-scan CCD camera
at a magniﬁcation of 80,000× or 100,000×.
Scanning Electron Microscopy (SEM). SEM imaging was
performed using a Nova 230 Nano scanning electron microscope.
The accelerating voltage was 10 kV. The samples were viewed at an
electron spot size of three. The detector mode was “through-the-lens”
secondary electron detector. The SERS substrate was mounted on the
stage by double-coated carbon-conductive tape. Images were taken at
a magniﬁcation of 35,000× or 50,000×.
Western Blotting. Protein concentration was estimated using a
BCA protein-assay kit (ThermoFisher Scientiﬁc, USA). Proteins were
mixed with NuPAGE LDS Sample Buﬀer containing 5% β-
mercaptoethanol and heated at 90 °C for 10 min. 20 μg of protein
extracts were fractionated on 4−12% NuPAGE Bis-Tris gels and
electrotransferred onto nitrocellulose membranes (ThermoFisher
Scientiﬁc, USA). The membranes were then blocked in 5% skim
milk in tris-buﬀered saline containing 0.1% Tween-20 (TBST) for 1 h
at room temperature and then were incubated overnight at 4 °C with
appropriate primary antibodies at 1:2000 dilution in blocking
solution. After three washes with TBST for 10 min each,
horseradish-peroxidase-conjugated secondary antibodies (Thermo-
Fisher Scientiﬁc) at 1:5000 dilution in blocking solution were added,
and the membranes were incubated for 1 h at room temperature.
SuperSignal West Femto maximum sensitivity substrate (Thermo
Fisher Scientiﬁc, USA) was added, and protein bands were visualized
using a Gel-Doc apparatus (Syngene, USA).
Statistical and Principal Component Analyses. Statistical
analysis was done using Origin 8.0. Results were considered
signiﬁcant at p < 0.05. PCA is a statistical procedure that uses an
orthogonal transformation to convert a set of observations of possibly
correlated variables into a set of values of linearly uncorrelated
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variables called principal components (or sometimes, principal modes
of variation). In our study, the correlated variables were the vectors
including Raman shift and the related Raman intensity of each Raman
spectrum. This orthogonal transformation was deﬁned so that the ﬁrst
principal component (PC1) had the largest possible variance (i.e.,
accounted for as much of the variability in the data as possible), and
each succeeding component (PC2, PC3, etc.) in turn had the highest
variance possible under the constraint that it is orthogonal to the
preceding components. The results are presented using PC1 and PC2
(Figure 6D). To obtain these results, ﬁrst, the background of the
Raman spectrum was subtracted and the data were saved in .txt
format. Then, PCA analysis was performed using an in-house-coded
program running on a Python compiler. Sixteen vectors were chosen
along the Raman shift axis (847, 854, 1043, 1163, 1181, 1202, 1213,
1255, 1269, 1309, 1374, 1384, 1421, 1429, 1482, and 1506 cm−1) for
fully regenerating the original spectra. The data were visualized using
an in-house-written program in R Studio.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acssen-
sors.8b01564.
Three tables of Raman peak assignments and corre-
sponding references (PDF)
■ AUTHOR INFORMATION
Corresponding Authors
*E-mail: gbitan@mednet.ucla.edu. Phone: 310-206-2082.
*E-mail: yhx@ucla.edu. Phone: (310)259-6946.
ORCID
Gal Bitan: 0000-0001-7046-3754
Author Contributions
#Z. Y. and S. D. contributed equally to the work.
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
We thank Dr. Farid Rahimi, Australian National University,
Canberra, for editorial help. This work was funded by a grant
from the United States Government and the generous support
of the American people through the United States Department
of State and the United States Agency for International
Development (USAID) under the Pakistan−U.S Science &
Technology Cooperation Program. The contents do not
necessarily reﬂect the views of the United States Government.
Y.H.X. acknowledges partial support from Zhejiang University
Cao Guang-Biao Advanced Science and Technology Fund and
from an Alexander von Humboldt Foundation Research
Award. G.B. acknowledges support from Team Parkinson/
Parkinson Alliance, a pilot grant from the UCLA American
Parkinson’s Disease Association (APDA) Center, and grant
2017-10-007 from the MSA Coalition.
■ REFERENCES
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